Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.02
42% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $24.2K | $89.3K | $119.0K | $89.0K | $69.0K | $59.0K | $42.0K |
| Gross profit | $0 | −$24.2K | −$89.3K | −$119.0K | −$89.0K | −$69.0K | −$59.0K | −$42.0K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $944.0K | $862.7K | $1.3M | $1.2M | $1.2M | $1.7M | $2.4M | $1.1M |
| Operating income | −$1.8M | −$2.0M | −$2.6M | −$2.4M | −$2.8M | −$3.5M | −$4.9M | −$2.8M |
| EBITDA | −$105.8K | −$1.9M | −$2.2M | −$2.1M | −$2.5M | −$3.2M | −$4.7M | −$2.7M |
| Net income | −$1.7M | −$2.0M | −$2.4M | −$2.5M | −$3.8M | −$4.9M | −$6.2M | −$1.6M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.12 | -0.12 | -0.10 | -0.10 | -0.13 | -0.14 | -0.13 | -0.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $0 | $0.47 | $0.47–$0.47 | 1 |
| 2028 | $0 | $1.28 | $1.28–$1.28 | 1 |
Forward consensus · source: Financial Modeling Prep
CHITOGENX INC
No one on the platform currently holds CHNXF.
No tracked institution reports a position in CHNXF as of their last filing.
No one on the platform has traded CHNXF yet.
| $90309 |
| — |
| NBIONascent Biotech, Inc. | $0.00 | +0.00% | $86109 | — |
| RASPActavia Life Sciences, Inc. | $0.00 | +0.00% | $385906 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CHNXF CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM https://www.stocktitan.net/news/CHNXF/chitogenx-launches-burn-and-skin-repair-development-cuo3ivd0ab32.html
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Non-Brokered Private Placement 2nd Tranche Closed; Clarification And Revision $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-non-brokered-private-placement-2nd-tranche-closed-clarification-and-revision
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – FY2023 Ending January 31, 2023 Reported $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-fy2023-ending-january-31-2023-reported
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Third Time’s the Charm? Non-Brokered Private Placement Terms Amended Again $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-third-times-the-charm-non-brokered-private-placement-terms-amended-again
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – New Private Placement Offering Announced $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-new-private-placement-offering-announced
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Grant Awarded to Develop New Opportunities and Indications $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-grant-awarded-to-develop-new-opportunities-and-indications
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Proof of Concept Confirmed in Meniscus Tear Repair Study $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-proof-of-concept-confirmed-in-meniscus-tear-repair-study
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Offering Announced; Increasing Price Target $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-offering-announced-increasing-price-target
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – FQ3 2023 Reported; Advancing The Opportunities $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-fq3-2023-reported-advancing-the-opportunities
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.